Results 121 to 130 of about 6,419 (213)
Using therapeutics to prevent and treat COVID-19 [PDF]
Distributed via the CDC Health Alert NetworkFriday, December 31, 2021, 5:00 PM ETCDCHAN-00461The SARS-CoV-2 Omicron variant has quickly become the dominant variant of concern in the United States and is present in all 50 states.
core
Interim clinical considerations for COVID-19 treatment in outpatients [PDF]
Updated June 15, 2022This page provides a treatment overview for healthcare providers ...
core
Background Large Language Models (LLMs), enhanced with Clinical Practice Guidelines (CPGs), can significantly improve Clinical Decision Support (CDS). However, methods for incorporating CPGs into LLMs are not well studied.
Kapoor, Sumit +6 more
core
Cardiovascular Outcomes in COVID-19 Patients Treated with Paxlovid: A Multicenter Retrospective Study. [PDF]
Chen WL +10 more
europepmc +1 more source
Safety and efficacy of major antiviral and immune therapies in pregnancy for maternal viral infections: evidence synthesis of maternal and neonatal outcomes. [PDF]
Sleman S +4 more
europepmc +1 more source
Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid<sup>®</sup> in a Long COVID cohort: a case series. [PDF]
Pridgen WL, Putrino D.
europepmc +1 more source
Hospital Methodology for Steering on Patient Value:Healthcare Outcomes in Relation to Costs [PDF]
Gilissen, L. +3 more
core +2 more sources
Carfilzomib Induced Microangiopathy due to Accumulation With Paxlovid
Philipponnet, Carole +4 more
openaire +2 more sources

